Surgical outcome and pathological effects of bromocriptine preoperative treatment in prolactinomas.

[1]  F. Peillon,et al.  Resistance to bromocriptine in prolactinomas. , 1989, The Journal of clinical endocrinology and metabolism.

[2]  G. Tindall,et al.  Management of prolactinomas associated with very high serum prolactin levels. , 1988, Journal of neurosurgery.

[3]  R. Fahlbusch,et al.  Short-term preoperative treatment of macroprolactinomas by dopamine agonists. , 1987, Journal of neurosurgery.

[4]  B. Scheithauer,et al.  Prolactin-secreting adenomas: the preoperative response to bromocriptine treatment and surgical outcome. , 1987, Journal of neurosurgery.

[5]  M. Esiri,et al.  Effect of bromocriptine treatment on the fibrous tissue content of prolactin-secreting and nonfunctioning macroadenomas of the pituitary gland. , 1986, The Journal of clinical endocrinology and metabolism.

[6]  D. Lüdecke,et al.  In-vitro effects of bromocriptine on isolated pituitary adenoma cells. Ultrastructural and morphometrical studies. , 1985, Pathology, research and practice.

[7]  J. Hassoun,et al.  Bromocriptine effects on cultured human prolactin-producing pituitary adenomas: in vitro ultrastructural, morphometric, and immunoelectron microscopic studies. , 1985, The Journal of clinical endocrinology and metabolism.

[8]  H. Mogami,et al.  Effects of bromocriptine on prolactin‐secreting pituitary adenomas. Mechanism of reduction in tumor size evaluated by light and electron microscopic, immunohistochemical, and morphometric analysis , 1985, Cancer.

[9]  M. Molitch,et al.  Bromocriptine as Primary Therapy for Prolactin-Secreting Macroadenomas: Results of a Prospective Multicenter Study* , 1985 .

[10]  V. Osterwalder,et al.  Perivascular fibrosis in prolactinomas: is it increased by bromocriptine? , 1984, The Journal of clinical endocrinology and metabolism.

[11]  J. Hardy,et al.  Combined Medical and Surgical Treatment of Prolactin-Producing Pituitary Tumors , 1984 .

[12]  G. Giannattasio,et al.  Bromocriptine treatment reduces the cell size in human macroprolactinomas: a morphometric study. , 1984, The Journal of clinical endocrinology and metabolism.

[13]  K. Kovacs,et al.  Clinical and pathological effects of bromocriptine on prolactin-secreting and other pituitary tumors. , 1984, Journal of neurosurgery.

[14]  J. Moossy,et al.  Factors in predicting outcome from operation in patients with prolactin-secreting pituitary adenomas. , 1983, Neurosurgery.

[15]  D. Topliss,et al.  Failure of bromocriptine to maintain reduction in size of a macroprolactinoma. , 1983, British medical journal.

[16]  S. Feldon,et al.  Bromocriptine treatment of prolactin-secreting tumors: surgical implications. , 1983, Neurosurgery.

[17]  M. Apuzzo,et al.  Natural history of microprolactinomas: six-year follow-up. , 1983, Neurosurgery.

[18]  C. Tonon,et al.  Reenlargement of macroprolactinomas during bromocriptine treatment: report of two cases , 1983, Journal of endocrinological investigation.

[19]  G. Faglia,et al.  INFLUENCE OF PREVIOUS BROMOCRIPTINE THERAPY ON SURGERY FOR MICROPROLACTINOMA , 1983, The Lancet.

[20]  K. Kovacs,et al.  Presence of Human Prolactin-Producing Adenomas and Bromocriptine: A Histological, Immunocytochemical, Ultrastructural, and Morphometric Study , 1982 .

[21]  E. Froesch,et al.  BROMOCRIPTINE: DOES IT JEOPARDISE THE RESULT OF LATER SURGERY FOR PROLACTINOMAS? , 1982, The Lancet.

[22]  T. Tomita,et al.  Structural changes in human pituitary tumor after bromocriptine therapy. , 1982, Neurosurgery.

[23]  G. Tindall,et al.  Transsphenoidal microsurgery for prolactin-secreting pituitary adenomas. , 1982, Journal of Neurosurgery.

[24]  A. Rogol,et al.  Rapid changes of prolactinoma volume after withdrawal and reinstitution of bromocriptine. , 1981, The Journal of clinical endocrinology and metabolism.

[25]  C. Wilson,et al.  Bromocriptine treatment of pituitary adenomas. , 1981, Neurosurgery.

[26]  F. Peillon,et al.  Endocrine outcome after transsphenoidal adenomectomy for prolactinoma: prolactin levels and tumor size as predicting factors. , 1980, Surgical neurology.

[27]  V. Hemming,et al.  PENICILUNASE-PRODUCING NEISSERIA GONORRHŒÆ , 1976, The Lancet.